Literature DB >> 15496528

Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review.

M Schneemann1, R Cathomas, S T Laidlaw, A M El Nahas, R D G Theakston, D A Warrell.   

Abstract

BACKGROUND: The desert horned vipers (Cerastes cerastes and C. gasperettii) are the most familiar snakes of the great deserts of North Africa and the Middle East, including the plains of Iraq. They are responsible for many human snake bites. In Western countries, they are popular among exotic-snake keepers. AIM: To investigate mechanisms of life-threatening envenoming and treatment.
DESIGN: Clinical investigation.
METHODS: Clinical and laboratory studies with measurement of serum venom antigen concentrations by enzyme immunoassay.
RESULTS: Two men bitten while handling captive Saharan horned vipers (Cerastes cerastes) in Europe developed extensive local swelling and life-threatening systemic envenoming, characterized by coagulopathy, increased fibrinolysis, thrombocytopenia, micro-angiopathic haemolytic anaemia and acute renal failure. The clinical picture is explicable by the presence in C. cerastes venom of several thrombin-like, Factor-X-activating, platelet-aggregating, haemorrhagic and nephrotoxic components. In one case, prophylactic use of subcutaneous epinephrine may have contributed to intracranial haemorrhage. The roles in treatment of heparin (rejected) and specific antivenom (recommended) are discussed. DISCUSSION: Cerastes cerastes is capable of life-threatening envenoming in humans. Optimal treatment of envenoming is by early administration of specific antivenom, and avoidance of ineffective and potentially-dangerous ancillary methods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496528     DOI: 10.1093/qjmed/hch118

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  19 in total

Review 1.  Treatment of bites by adders and exotic venomous snakes.

Authors:  David A Warrell
Journal:  BMJ       Date:  2005-11-26

2.  Efficacy of North American crotalid antivenom against the African viper Bitis gabonica (Gaboon viper).

Authors:  William J Meggs; Christopher N Wiley; Kori L Brewer; Jason B Hack
Journal:  J Med Toxicol       Date:  2010-03

3.  Bothrops jararaca envenomation: Pathogenesis of hemostatic disturbances and intravascular hemolysis.

Authors:  Luana V Senise; Karine M Yamashita; Marcelo L Santoro
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-16

4.  Update of acute kidney injury: intensive care nephrology.

Authors:  G Tsagalis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

5.  Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.

Authors:  Simon C Wagstaff; Gavin D Laing; R David G Theakston; Christina Papaspyridis; Robert A Harrison
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

6.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

7.  Thrombotic microangiopathy following saw-scaled viper (Echis carinatus) envenoming in Sri Lanka.

Authors:  Selladurai Pirasath; Chandrakulasegeran Athirayan; Dilani Gajan
Journal:  SAGE Open Med Case Rep       Date:  2021-07-13

8.  [Hemorrhagic stroke following a fatal envenomation by a horned viper in Tunisia].

Authors:  Hassen Ben Ghezala; Salah Snouda
Journal:  Pan Afr Med J       Date:  2015-06-24

9.  Dosage comparison of snake anti-venomon coagulopathy.

Authors:  Ali Hassan Rahmani; Amir Jalali; Mohammad Hassan Alemzadeh-Ansari; Mina Tafazoli; Fakher Rahim
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

10.  Naja naja karachiensis envenomation: biochemical parameters for cardiac, liver, and renal damage along with their neutralization by medicinal plants.

Authors:  Muhammad Hassham Hassan Bin Asad; Ghulam Murtaza; Muhammad Ubaid; Ashif Sajjad; Rubada Mehmood; Qaisar Mahmood; Muhammad Muzzmil Ansari; Sabiha Karim; Zahid Mehmood; Izhar Hussain
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.